ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02019693
Brief Title: A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer

First Submitted : December 20, 2013
First Submitted that Met QC Criteria : December 20, 2013
First Posted : December 24, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : August 7, 2018
Last Update Posted : August 8, 2018